Reconstruction of the SEY evolution during the 2022 LHC scrubbing run

During each long shutdown of the Large Hadron Collider (LHC), the surface of the beam screens are expected to decondition, favoring the formation of dense electron clouds, which generate high heat loads on the cryogenic system of the superconducting magnets. A scrubbing run took place soon after the restart of the LHC for Run 3 (2022) in order to recondition the beam screens and limit the electron cloud formation such that the induced heat loads can be handled by the cryogenic system. We performed electron cloud build-up simulations using real beam data extracted from the LHC logging system and inferred the Secondary Emission Yield (SEY) by comparing simulations with experimental measurements of heat load. The vast amount of data that is logged during the scrubbing run allowed the systematic study of the SEY and its evolution in different regions like the regular arc half-cells and the instrumented half-cells. Finally, a method was defined and used in order to disentangle the heat load contribution of the dipole and quadrupole magnets in a half-cell when only the total heat load is available

Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy.

One of the recently emerging anticancer strategies is the use of natural dietary compounds, such as sulforaphane, a cancer-chemopreventive isothiocyanate found in broccoli. Based on the growing evidence, sulforaphane acts through molecular mechanisms that interfere with multiple oncogenic pathways in diverse tumor cell types. Herein, we investigated the anticancer effects of bioavailable concentrations of sulforaphane in ovarian carcinoma cell line A2780 and its two derivatives, adriamycin-resistant A2780/ADR and cisplatin-resistant A2780/CP cell lines. Since tumor microenvironment is characterized by reduced oxygenation that induces aggressive tumor phenotype (such as increased invasiveness and resistance to chemotherapy), we evaluated the effects of sulforaphane in ovarian cancer cells exposed to hypoxia (2% O2). Using the cell-based reporter assay, we identified several oncogenic pathways modulated by sulforaphane in hypoxia by activating anticancer responses (p53, ARE, IRF-1, Pax-6 and XRE) and suppressing responses supporting tumor progression (AP-1 and HIF-1). We further showed that sulforaphane decreases the level of HIF-1alpha protein without affecting its transcription and stability. It can also diminish transcription and protein level of the HIF-1 target, CA IX, which protects tumor cells from hypoxia-induced pH imbalance and facilitates their migration/invasion. Accordingly, sulforaphane treatment leads to diminished pH regulation and reduced migration of ovarian carcinoma cells. These effects occur in all three ovarian cell lines suggesting that sulforaphane can overcome the chemoresistance of cancer cells. This offers a path potentially exploitable in sensitizing resistant cancer cells to therapy, and opens a window for the combined treatments of sulforaphane either with conventional chemotherapy, natural compounds, or with other small molecules

Accelerated increase in plant species richness on mountain summits is linked to warming

We thank D. Barolin, J. Birks, A. Björken, C. Björken, S. Dahle, U. Deppe, G. Dussassois, J. V. Ferrández, T. Gassner, S. Giovanettina, F. Giuntoli, Ø. Lunde Heggebø, K. Herz, A. Jost, K. Kallnik, W. Kapfer, T. Kronstad, H. Laukeland, S. Nießner, M. Olson, P. Roux-Fouillet, K. Schofield, M. Suen, D. Watson, J. Wells Abbott, J. Zaremba and numerous additional helpers for fieldwork support; P. Barancˇ ok, J. L. Benito Alonso, M. Camenisch, G. Coldea, J. Dick, M. Gottfried, G. Grabherr, J. I. Holten, J. Kollár, P. Larsson, M. Mallaun, O. Michelsen, U. Molau, M. Pus¸  cas¸ , T. Scheurer, P. Unterluggauer, L. Villar, G.-R. Walther, and numerous helpers for data originating from the GLORIA network13; C. Jenks for linguistic support; and the following institutions for funding. M.J.S.: Danish Carlsbergfondet (CF14-0148), EU Marie Sklodowska-Curie action (grant 707491). C.R., V.S., S.W.: Velux Foundation, Switzerland. C.R., V.S., S.W., J.-P.T., P.V.: Swiss Federal Office for the Environment (FOEN). A.K.: Swiss National Science Foundation (31003A_144011 to C.R.), Basler Stiftung für biologische Forschung, Switzerland. J.K.: Fram Centre, Norway (362202). J.K., J.-A.G., P.C., B.J.: Polish-Norwegian Research Programme of the Norwegian National Centre for Research and Development (Pol-Nor/196829/87/2013). O.F.-A., M.J.H., S.P.: Instituto de Estudios Altoaragoneses (Huesca, Spain). S.D.: Austrian Climate Research Programme (ACRP, project 368575: DISEQU-ALP). F.J.: Botanical Society of Britain & Ireland; Alpine Garden Society, UK. M.J.H.: Felix de Azara research grant (IBERSUMIT project, DPH, Spain). R.K.: Slovak Research and Development Agency (APVV 0866-12). S.N., D.G.: VILLUM Foundation’s Young Investigator Programme (VKR023456; Denmark). S.P.: Ramón y Cajal fellowship (RYC-2013-14164, Ministerio de Economía y Competitividad, Spain). J.-C.S.: European Research Council (ERC-2012-StG-310886-HISTFUNC); VILLUM Investigator project (VILLUM FONDEN grant 16549; Denmark). S.W.: WSL internal grant (201307N0678, Switzerland); EU FP7 Interact Transnational Access (AlpFlor Europe). S.W., S.B., F.J., M.J.H.: Swiss Botanical Society Alpine Flower Fund. Time and effort was supported by sDiv, the Synthesis Centre of iDiv, Germany (DFG FZT 118, sUMMITDiv working group).Peer reviewedPostprin